Yuyu Pharma Statistics

Total Valuation

Yuyu Pharma has a market cap or net worth of KRW 73.06 billion. The enterprise value is 76.48 billion.

Market Cap	73.06B
Enterprise Value	76.48B

Important Dates

The next estimated earnings date is Tuesday, May 13, 2025.

Earnings Date	May 13, 2025
Ex-Dividend Date	Dec 27, 2024

Share Statistics

Yuyu Pharma has 16.18 million shares outstanding. The number of shares has increased by 3.29% in one year.

Current Share Class	16.18M
Shares Outstanding	16.18M
Shares Change (YoY)	+3.29%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	34.99%
Owned by Institutions (%)	0.09%
Float	10.52M

Valuation Ratios

The trailing PE ratio is 9.75.

PE Ratio	9.75
Forward PE	n/a
PS Ratio	0.55
PB Ratio	0.54
P/TBV Ratio	0.61
P/FCF Ratio	4.10
P/OCF Ratio	2.93
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 4.18, with an EV/FCF ratio of 4.29.

EV / Earnings	10.10
EV / Sales	0.57
EV / EBITDA	4.18
EV / EBIT	6.05
EV / FCF	4.29

Financial Position

The company has a current ratio of 1.58, with a Debt / Equity ratio of 0.25.

Current Ratio	1.58
Quick Ratio	0.97
Debt / Equity	0.25
Debt / EBITDA	1.84
Debt / FCF	1.89
Interest Coverage	3.91

Financial Efficiency

Return on equity (ROE) is 8.06% and return on invested capital (ROIC) is 4.79%.

Return on Equity (ROE)	8.06%
Return on Assets (ROA)	3.87%
Return on Invested Capital (ROIC)	4.79%
Return on Capital Employed (ROCE)	8.79%
Revenue Per Employee	526.27M
Profits Per Employee	29.94M
Employee Count	253
Asset Turnover	0.66
Inventory Turnover	1.98

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -4.95% in the last 52 weeks. The beta is 0.53, so Yuyu Pharma's price volatility has been lower than the market average.

Beta (5Y)	0.53
52-Week Price Change	-4.95%
50-Day Moving Average	4,514.10
200-Day Moving Average	4,597.45
Relative Strength Index (RSI)	45.75
Average Volume (20 Days)	81,633

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Yuyu Pharma had revenue of KRW 133.15 billion and earned 7.58 billion in profits. Earnings per share was 462.90.

Revenue	133.15B
Gross Profit	51.37B
Operating Income	12.58B
Pretax Income	9.98B
Net Income	7.58B
EBITDA	18.25B
EBIT	12.58B
Earnings Per Share (EPS)	462.90

Full Income Statement

Balance Sheet

The company has 42.65 billion in cash and 33.64 billion in debt, giving a net cash position of 9.01 billion or 556.48 per share.

Cash & Cash Equivalents	42.65B
Total Debt	33.64B
Net Cash	9.01B
Net Cash Per Share	556.48
Equity (Book Value)	135.06B
Book Value Per Share	7,578.44
Working Capital	37.47B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 24.95 billion and capital expenditures -7.11 billion, giving a free cash flow of 17.84 billion.

Operating Cash Flow	24.95B
Capital Expenditures	-7.11B
Free Cash Flow	17.84B
FCF Per Share	1,102.29

Full Cash Flow Statement

Margins

Gross margin is 38.58%, with operating and profit margins of 9.45% and 6.55%.

Gross Margin	38.58%
Operating Margin	9.45%
Pretax Margin	7.50%
Profit Margin	6.55%
EBITDA Margin	13.71%
EBIT Margin	9.45%
FCF Margin	13.40%

Dividends & Yields

This stock pays an annual dividend of 100.00, which amounts to a dividend yield of 2.19%.

Dividend Per Share	100.00
Dividend Yield	2.19%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.29%
Shareholder Yield	-1.10%
Earnings Yield	10.37%
FCF Yield	24.41%

Dividend Details

Stock Splits

The last stock split was on March 30, 2021. It was a forward split with a ratio of 2.

Last Split Date	Mar 30, 2021
Split Type	Forward
Split Ratio	2

Scores

Yuyu Pharma has an Altman Z-Score of 1.87. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.87
Piotroski F-Score	n/a